Аутоиммунные нарушения при первичных иммунодефицитах
https://doi.org/10.14412/1996-7012-2025-3-109-114
Аннотация
В соответствии с современными представлениями о механизмах формирования первичных иммунодефицитов (ПИД) и особенностях их течения существует отчетливая и клинически значимая взаимосвязь заболеваний этой группы с аутоиммунными нарушениями (АИН).
В статье представлены актуальные данные об АИН у больных ПИД с акцентом на наиболее часто встречающиеся заболевания и основные проявления, которые требуют включения ПИД в круг дифференциально-диагностического поиска у пациента с ревматическим заболеванием.
При поддержке: Статья подготовлена в рамках фундаментальной научной темы №1021051302580-4.
Об авторах
М. И. Каледа
ФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой»
Россия
Россия
Мария Игоревна Каледа
115522, Москва, Каширское шоссе, 34А
И. П. Никишина
ФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой»
Россия
Россия
115522, Москва, Каширское шоссе, 34А
Литература
1. Fischer A, Provot J, Jais JP, et al; members of the CEREDIH French PID study group. Autoimmune and inflammatory manifestations occur frequently in patients with primary immunodeficiencies. J Allergy Clin Immunol. 2017 Nov;140(5):1388-1393.e8. doi: 10.1016/j.jaci.2016.12.978. Epub 2017 Feb 10.
2. Bousfiha A, Moundir A, Tangye SG, et al. The 2022 Update of IUIS Phenotypical Classification for Human Inborn Errors of Immunity. J Clin Immunol. 2022 Oct;42(7):1508- 1520. doi: 10.1007/s10875-022-01352-z. Epub 2022 Oct 6.
3. Azizi G, Pouyani MR, Abolhassani H, et al. Cellular and molecular mechanisms of immune dysregulation and autoimmunity. Cell Immunol. 2016 Dec:310:14-26. doi: 10.1016/j.cellimm.2016.08.012. Epub 2016 Aug 27.
4. Grimbacher B, Warnatz K, Yong PFK, et al. The crossroads of autoimmunity and immunodeficiency: Lessons from polygenic traits and monogenic defects. J Allergy Clin Immunol. 2016 Jan;137(1):3-17. doi: 10.1016/j.jaci.2015.11.004.
5. Atkinson TP. Immune deficiency and autoimmunity. Curr Opin Rheumatol. 2012 Sep;24(5):515-21. doi: 10.1097/BOR.0b013e32835680c6.
6. Azizi G, Ziaee V, Tavakol M, et al. Approach to the Management of Autoimmunity in Primary Immunodeficiency. Scand J Immunol. 2017 Jan;85(1):13-29. doi: 10.1111/sji.12506.
7. Westerberg LS, Klein C, Snapper SB. Breakdown of T cell tolerance and autoimmunity in primary immunodeficiency – lessons learned from monogenic disorders in mice and men. Curr Opin Immunol. 2008 Dec;20(6): 646-54. doi: 10.1016/j.coi.2008.10.004. Epub 2008 Nov 12.
8. Anaya JM. The autoimmune tautology. A summary of evidence. Joint Bone Spine. 2017 May;84(3):251-253. doi: 10.1016/j.jbspin.2016.11.012. Epub 2016 Dec 23.
9. Abolhassani H, Gharib B, Shahinpour S, et al. Autoimmunity in patients with selective IgA deficiency. J Investig Allergol Clin Immunol. 2015;25(2):112-9
10. Kaplan MY, Ozen S, Akcal O, et al. Autoimmune and inflammatory manifestations in pediatric patients with primary immunodeficiencies and their importance as a warning sign. Allergol Immunopathol (Madr). 2020 Nov-Dec;48(6):701-710. doi: 10.1016/j.aller.2020.02.009. Epub 2020 May 20.
11. Baris HE, Kiyk m A, Nain E, et al. The plethora, clinical manifestations and treatment options of autoimmunity in patients with primary immunodeficiency. Turk Pediatri Ars. 2016 Dec 1;51(4):186-192. doi: 10.5152/TurkPediatriArs.2016.3928. eCollection 2016 Dec.
12. Tahiat A, Yagoubi A, Ladj MS, et al. Diagnostic and Predictive Contribution of Autoantibodies Screening in a Large Series of Patients With Primary Immunodeficiencies. Front Immunol. 2021 Apr 1:12:665322. doi: 10.3389/fimmu.2021.665322. eCollection 2021.
13. Westermann-Clark E, Meehan CA, Meyer AK, et al. Primary Immunodeficiency in Children With Autoimmune Cytopenias: Retrospective 154-Patient Cohort. Front Immunol. 2021 Apr 22:12:649182. doi: 10.3389/fimmu.2021.649182. eCollection 2021.
14. Patuzzo G, Barbieri A, Tinazzi E, et al. Autoimmunity and infection in common variable immunodeficiency (CVID). Autoimmun Rev. 2016 Sep;15(9):877-82. doi: 10.1016/j.autrev.2016.07.011. Epub 2016 Jul 6.
15. Sudhakar M, Rikhi R, Loganathan SK, et al. Autoimmunity in Wiskott-Aldrich Syndrome: Updated Perspectives. Appl Clin Genet. 2021 Aug 20:14:363-388. doi: 10.2147/TACG.S213920. eCollection 2021.
16. Odineal DD, Gershwin ME. The Epidemiology and Clinical Manifestations of Autoimmunity in Selective IgA Deficiency. Clin Rev Allergy Immunol. 2020 Feb;58(1):107-133. doi: 10.1007/s12016-019-08756-7.
17. Boyle RJ, Le C, Balloch A, Tang ML. The clinical syndrome of specific antibody deficiency in children. Clin Exp Immunol. 2006 Dec;146(3):486-92. doi: 10.1111/j.1365-2249.2006.03242.x.
18. Jara LJ, Medina G, Saavedra MA. Autoimmune manifestations of infections. Curr Opin Rheumatol. 2018 Jul;30(4):373-379. doi: 10.1097/BOR.0000000000000505.
19. Modell V, Orange JS, Quinn J, Modell F. Global report on primary immunodeficiencies: 2018 update from the Jeffrey Modell Centers Network on disease classification, regional trends, treatment modalities, and physician reported outcomes. Immunol Res. 2018 Jun;66(3):367-380. doi: 10.1007/s12026-018-8996-5.
20. Bonilla FA, Khan DA, Ballas ZK, et al; Joint Task Force on Practice Parameters, representing the American Academy of Allergy, Asthma & Immunology; the American College of Allergy, Asthma & Immunology; and the Joint Council of Allergy, Asthma & Immunology. Practice parameter for the diagnosis and management of primary immunodeficiency. J Allergy Clin Immunol. 2015 Nov; 136(5):1186-205.e1-78. doi: 10.1016/j.jaci.2015.04.049. Epub 2015 Sep 12.
21. Gathmann B, Mahlaoui N, Gerard L, et al; CEREDIH. European Society for Immunodeficiencies Registry Working Party. Clinical picture and treatment of 2212 patients with common variable immunodeficiency. J Allergy Clin Immunol. 2014 Jul;134(1):116-26. doi: 10.1016/j.jaci.2013.12.1077. Epub 2014 Feb 28.
22. Chapel H, Lucas M, Patel S, et al. Confirmation and improvement of criteria for clinical phenotyping in common variable immunodeficiency disorders in replicate cohorts. J Allergy Clin Immunol. 2012 Nov;130(5): 1197-1198.e9. doi: 10.1016/j.jaci.2012.05.046. Epub 2012 Jul 20.
23. Azizi G, Kiaee F, Hedayat E, et al. Rheumatologic complications in a cohort of 227 patients with common variable immunodeficiency. Scand J Immunol. 2018 May;87(5): e12663. doi: 10.1111/sji.12663.
24. Gutierrez MJ, Sullivan KE, Fuleihan R, Bingham CO 3rd; USIDNET Consortium. Phenotypic characterization of patients with rheumatologic manifestations of common variable immunodeficiency. Semin Arthritis Rheum. 2018 Oct;48(2):318-326. doi: 10.1016/j.semarthrit.2018.02.013. Epub 2018 Feb 23.
25. Bogaert DJ, Dullaers M, Lambrecht BN, et al. Genes associated with common variable immunodeficiency: one diagnosis to rule them all? J Med Genet. 2016 Sep;53(9):575-90. doi: 10.1136/jmedgenet-2015-103690. Epub 2016 Jun 1.
26. Fraczek P, Szczepanek M, Tabarkiewicz J. Coincidence of selective immunoglobulin A deficiency in juvenile idiopathic arthritis – a series of three cases. Cent Eur J Immunol. 2021; 46(4):531-534. doi: 10.5114/ceji.2021.111200. Epub 2021 Dec 6.
27. Swain S, Selmi C, Gershwin ME, Teuber SS. The clinical implications of selective IgA deficiency. J Transl Autoimmun. 2019 Nov 23:2:100025. doi: 10.1016/j.jtauto.2019.100025. eCollection 2019 Dec.
28. Ludvigsson JF, Neovius M, Hammarström L. Association between IgA deficiency & other autoimmune conditions: a population-based matched cohort study. J Clin Immunol. 2014;34(4):444-51. doi: 10.1007/s10875-014-0009-4
29. Wang N, Shen N, Vyse TJ, et al. Selective IgA deficiency in autoimmune diseases. Mol Med. 2011;17(11-12):1383-96. doi: 10.2119/molmed.2011.00195. Epub 2011 Aug 4.
30. Hirbod-Mobarakeh A, Aghamohammadi A, Rezaei N. Immunoglobulin class switch recombination deficiency type 1 or CD40 ligand deficiency: from bedside to bench and back again. Expert Rev Clin Immunol. 2014 Jan;10(1):91-105. doi: 10.1586/1744666X.2014.864554. Epub 2013 Nov 26.
31. Leven EA, Maffucci P, Ochs HD, et al. Hyper IgM Syndrome: a Report from the USIDNET Registry. J Clin Immunol. 2016 Jul;36(5):490-501. doi: 10.1007/s10875-016-0291-4. Epub 2016 May 17.
32. Banday AZ, Nisar R, Patra PK, et al. Clinical and Immunological Features, Genetic Variants, and Outcomes of Patients with CD40 Deficiency. J Clin Immunol. 2023 Dec 22;44(1):17. doi: 10.1007/s10875-023-01633-1.
33. Coulter TI, Chandra A, Bacon CM, et al. Clinical spectrum and features of activated phosphoinositide 3-kinase syndrome: A large patient cohort study. J Allergy Clin Immunol. 2017 Feb;139(2):597-606.e4. doi: 10.1016/j.jaci.2016.06.021. Epub 2016 Jul 16.
34. Dorjbal B, Stinson JR, Ma CA, et al. Hypomorphic caspase activation and recruitment domain 11 (CARD11) mutations associated with diverse immunologic phenotypes with or without atopic disease. J Allergy Clin Immunol. 2019 Apr;143(4):1482-1495. doi: 10.1016/j.jaci.2018.08.013. Epub 2018 Aug 28.
35. Sharifinejad N, Azizi G, Chavoshzadeh Z, et al. Autoimmunity in monogenic combined immune deficiencies with associated or syndromic features. Front Immunol. 2022 Dec 5:13:1023127. doi:10.3389/fimmu.2022.1023127. eCollection 2022.
36. Tison BE, Nicholas SK, Abramson SL, et al. Autoimmunity in a cohort of 130 pediatric patients with partial DiGeorge syndrome. J Allergy Clin Immunol. 2011 Nov; 128(5):1115-7.e1-3. doi: 10.1016/j.jaci.2011.06.043. Epub 2011 Aug 11.
37. Montin D, Marolda A, Licciardi F, et al. Immunophenotype Anomalies Predict the Development of Autoimmune Cytopenia in 22q11.2 Deletion Syndrome. J Allergy Clin Immunol Pract. 2019 Sep-Oct;7(7):2369-2376. doi: 10.1016/j.jaip.2019.03.014. Epub 2019 Mar 26.
38. Sudhakar M, Rikhi R, Loganathan SK, et al. Autoimmunity in Wiskott-Aldrich Syndrome: Updated Perspectives. Appl Clin Genet. 2021 Aug 20:14:363-388. doi: 10.2147/TACG.S213920. eCollection 2021.
39. Cannioto Z, Berti I, Martelossi S, et al. IBD and IBD mimicking enterocolitis in children younger than 2 years of age. Eur J Pediatr. 2009 Feb;168(2):149-55. doi: 10.1007/s00431-008-0721-2. Epub 2008 Jun 11.
40. Ohya T, Yanagimachi M, Iwasawa K, et al. Childhood-onset inflammatory bowel diseases associated with mutation of Wiskott-Aldrich syndrome protein gene. World J Gastroenterol. 2017 Dec 28;23(48):8544-8552. doi: 10.3748/wjg.v23.i48.8544.
41. Monteferrante G, Giani M, van den Heuvel M. Systemic lupus erythematosus and Wiskott-Aldrich syndrome in an Italian patient. Lupus. 2009 Mar;18(3):273-7. doi: 10.1177/0961203308095000.
42. Moratto D, Giliani S, Bonfim C, et al. Long-term outcome and lineage-specific chimerism in 194 patients with WiskottAldrich syndrome treated by hematopoietic cell transplantation in the period 1980-2009: an international collaborative study. Blood. 2011 Aug 11;118(6):1675-84. doi: 10.1182/blood-2010-11-319376. Epub 2011 Jun 9.
43. Brodszki N, Frazer-Abel A, Grumach AS, et al. European Society for Immunodeficiencies (ESID) and European Reference Network on Rare Primary Immunodeficiency, Autoinflammatory and Autoimmune Diseases (ERN RITA) Complement Guideline: Deficiencies, Diagnosis, and Management. J Clin Immunol. 2020 May;40(4):576-591. doi: 10.1007/s10875-020-00754-1. Epub 2020 Feb 17.
44. Wang SSY, Tang H, Loe MWC, et al. Complements and Their Role in Systemic Disorders. Cureus. 2024 Jan 26;16(1):e52991. doi: 10.7759/cureus.52991. eCollection 2024 Jan.
45. Stegert M, Bock M, Trendelenburg M. Clinical presentation of human C1q deficiency: How much of a lupus? Mol Immunol. 2015 Sep;67(1):3-11. doi: 10.1016/j.molimm.2015.03.007. Epub 2015 Apr 3.
46. McGonagle D, McDermott MF. A proposed classification of the immunological diseases. PLoS Med. 2006 Aug;3(8):e297. doi: 10.1371/journal.pmed.0030297.
47. Yamazaki-Nakashimada MA, SantosChavez EE, de Jesus AA, et al. Systemic Autoimmunity in a Patient With CANDLE Syndrome. J Investig Allergol Clin Immunol. 2019 Feb;29(1):75-76. doi: 10.18176/jiaci.0338.
48. Lamas A, Faria R, Marinho A, Vasconcelos C. The mosaic of systemic lupus erythematosus: From autoimmunity to autoinflammation and immunodeficiency and back. Autoimmun Rev. 2024 Dec;23(12):103675. doi: 10.1016/j.autrev.2024.103675. Epub 2024 Oct 29
Рецензия
Для цитирования:
Каледа МИ, Никишина ИП. Аутоиммунные нарушения при первичных иммунодефицитах. Современная ревматология. 2025;19(3):109-114. https://doi.org/10.14412/1996-7012-2025-3-109-114
For citation:
Kaleda MI, Nikishina IP. Autoimmune manifestations in primary immunodeficiencies. Sovremennaya Revmatologiya=Modern Rheumatology Journal. 2025;19(3):109-114. (In Russ.) https://doi.org/10.14412/1996-7012-2025-3-109-114
Просмотров:
112
Послать статью по эл. почте 